Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha
Puma Biotechnology Seen as Takeover Target After Strong Cancer Drug Data - TheStreet
Articles with Puma Biotechnology
Why is Puma Biotech Stock (PBYI) Plummeting Today?
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
PUM Stock Forecast, Price & News (Puma)
Puma Biotechnology
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
PUMA Biotechnology, Inc. Form S-1
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology: That's Some Target Increase!!! | Barron's
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
pbyi-def14a_20210615.htm
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer - Puma Biotechnology (NASDAQ:PBYI) - Benzinga
PBYI Stock Forecast, Price & News (Puma Biotechnology)
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology
Does Puma's quick Nerlynx launch play into its buyout prospects? | Fierce Pharma
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Is Puma Biotechnology a Buy? | The Motley Fool
PUMA BIOTECHNOLOGY, INC. General Corporate Statement (Form8) - Puma Biotechnology (NASDAQ:PBYI) - Benzinga
